Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical Therapies
Trial details
- Registry ID
- NCT07935590
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as ATI-2138
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of Modzatinib (ATI-2138) in Adult Participants With Biopsy-proven Forms of Lichen Planus Not Adequately Controlled With Topical TherapiesNCT07935590 | ACRS | Phase 2 | Recruiting | 2029-03Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |